Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.

Wyeth

Status and phase: Completed; Phase 3

Conditions: Depression

Treatments: Drug: Effexor XR

Study type: Interventional

Funder types: Industry

Identifiers

NCT00225524

0600B1-818

Details and patient eligibility

About

Phase III long-term safety study of Effexor XR in patients with major depression.

Enrollment: 150 estimated patients

Sex: All

Ages: 20 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who complete the Phase III double-blind study (Protocol Number 0600B1-816)

Exclusion criteria

• Patients with schizophrenia or any other psychotic disorder
• Patients with history or presence of bipolar disorder

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)